Literature DB >> 17081219

Defining the clinical characteristics of Peyronie's disease in young men.

Serkan Deveci1, Carin V Hopps, Keith O'Brien, Marilyn Parker, Patricia Guhring, John P Mulhall.   

Abstract

INTRODUCTION: Peyronie's disease (PD) is usually seen in men in their fifth decade of life. AIM: In this study, we investigated the characteristics of the disease in young men. MAIN OUTCOME MEASURES: The demographics, clinical features, and associated comorbidities of the patients with PD were retrospectively reviewed.
METHODS: The findings were compared between men with the disease who were under 40 years of age with those over 40 years. Statistical analyses were conducted to define differentiating features between these two groups.
RESULTS: Of the 296 patients, 32 were under the age of 40 years and 264 over 40 years. The mean duration of the disease was 2 +/- 4 and 6 +/- 8 months in the respective age groups. Fifty-six percent of the patients under the age of 40 years and 75% of the patients over this age presented with curvature (P < 0.01). Thirty-seven percent under 40 years and 12% men over 40 years had more than one plaque at presentation (P < 0.01). Dupuytren's contracture was seen only in patients over 40 years of age. Pain at presentation was found in 75% under the age of 40 years and in 65% over 40 years (P = 0.03). Trauma history was found in 18% under 40 years and in 5% over this age (P < 0.01). Statistical significant differences were found between the groups under and over the age of 40 years for hypertension (P < 0.01) and dyslipidemia (P < 0.01). Diabetes was noted in 50% of the patients under the age of 40 years and in 18% of the patients over this age (P < 0.001). Multivariate analysis of conditions associated in men with PD under 40 years of age showed statistical significant differences for diabetes (P = 0.015), presentation within 6 months (P = 0.004), and having multiple plaques (P = 0.008).
CONCLUSIONS: Young men with PD are more likely to present at an earlier stage of the disease, to have diabetes, and to have more than one plaque at the time of presentation.

Entities:  

Mesh:

Year:  2006        PMID: 17081219     DOI: 10.1111/j.1743-6109.2006.00344.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  10 in total

1.  Peyronie's Disease: Nonsurgical Therapy Options.

Authors:  Franklin E Kuehhas; Peter Weibl; Tosev Georgi; Nenad Djakovic; Ralf Herwig
Journal:  Rev Urol       Date:  2011

Review 2.  Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Nat Rev Urol       Date:  2010-03-09       Impact factor: 14.432

3.  Testosterone Levels Are Not Associated With Magnitude of Deformity in Men With Peyronie's Disease.

Authors:  John P Mulhall; Kazuhito Matsushita; Christian J Nelson
Journal:  J Sex Med       Date:  2019-07-11       Impact factor: 3.802

Review 4.  Current status of the surgical management of Peyronie's disease.

Authors:  Ates Kadioglu; Faruk Küçükdurmaz; Oner Sanli
Journal:  Nat Rev Urol       Date:  2011-02       Impact factor: 14.432

5.  Clinical and epidemiological characteristics of young patients with Peyronie's disease: a retrospective study.

Authors:  Gianni Paulis; Giorgio Cavallini; Davide Barletta; Paolo Turchi; Antonio Vitarelli; Andrea Fabiani
Journal:  Res Rep Urol       Date:  2015-07-09

Review 6.  Psychosexual Symptoms and Treatment of Peyronie's Disease Within a Collaborative Care Model.

Authors:  Rose Hartzell
Journal:  Sex Med       Date:  2014-12       Impact factor: 2.491

7.  The Prevalence of Peyronie's Disease in the United States: A Population-Based Study.

Authors:  Mark Stuntz; Anna Perlaky; Franka des Vignes; Tassos Kyriakides; Dan Glass
Journal:  PLoS One       Date:  2016-02-23       Impact factor: 3.240

8.  Fibroproliferative disorders and diabetes: Understanding the pathophysiologic relationship between Peyronie's disease, Dupuytren disease and diabetes.

Authors:  Martin K Gelbard; Joel Rosenbloom
Journal:  Endocrinol Diabetes Metab       Date:  2020-10-31

9.  Structured Self-Rated Response to Iontophoresis with Verapamil and Dexamethasone in Peyronie's Disease.

Authors:  Abas Kokab; Kevan Wylie; Patricia Allen; Abhijeeth Shetty; Debbie Davies-South
Journal:  Adv Urol       Date:  2014-04-03

10.  Peyronie's disease after urethral swab, an unusual complication: a case report.

Authors:  Gianni Paulis; Davide Barletta
Journal:  Res Rep Urol       Date:  2015-11-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.